Skip to main content

POSIBIL6 - Phase III

Clinical Trial Grant
Duke Scholars

Administered By

Duke Clinical Research Institute

Awarded By

CSL Behring LLC

Start Date

March 14, 2024

End Date

June 30, 2024
 

Administered By

Duke Clinical Research Institute

Awarded By

CSL Behring LLC

Start Date

March 14, 2024

End Date

June 30, 2024